PRospective Multiple Myeloma Impact Study
PRospective Multiple Myeloma Impact Study
Active, not recruiting · NCT02911571 · Registry updated 2026-04-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| PRospective Multiple Myeloma Impact Study | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Active, not recruiting | Not applicable | 2026-04-28 | NCT02911571 |
2 results · Page 1 of 1
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Columbia University Medical center | New York | United States | 224 |
| Hackensack University Medical Center | Hackensack | United States | 308 |
| Levine Cancer Institute | Charlotte | United States | 110 |
| Lombardi Comprehensive Cancer Center | Washington D.C. | United States | 5 |
| Medical College of Wisconsin | Milwaukee | United States | 483 |
| New York Presbyterian Brooklyn Methodist Hospital | Brooklyn | United States | 5 |
| Wake Forest Baptist Medical Center, | Winston-Salem | United States | 1 |
| Weill Cornell Medicine | New York | United States | 122 |
| Winship Cancer Institute, Emory University | Atlanta | United States | 47 |